FROM PRESS
to presentations

News

February 5, 2025
Revalesio Announces New Analyses from Phase 2 RESCUE Study of RNS60 in Patients with Acute Ischemic Stroke in Oral Presentation at the International Stroke Conference 2025
October 9, 2024
REVALESIO’S INVESTIGATIONAL TREATMENT RNS60 PROTECTS MITOCHONDRIA IN PRECLINICAL MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
September 17, 2024
REVALESIO’S INVESTIGATIONAL RNS60 EXTENDED SURVIVAL IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) IN POST-HOC ANALYSIS OF PHASE 2 INVESTIGATOR-SPONSORED TRIAL
All news